source
- FDA acting director of cell and gene therapies Vijay Kumar to depart his postVijay Kumar, who has been serving as the acting director of the Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products, announced he will leave his position. In an inte…
- STAT+: All of Us tests a new approach to collect real-world data for researchThe NIH All of Us Research Program has secured thousands of electronic medical records through an innovative use of patient data-sharing networksSTAT · 1mo ago↗ source
- STAT+: Investors double down on Bain-backed startupFDA's top gene therapy regulator steps down, Trump's plan to lower GLP-1 prices, and more biotech news